C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma

作者: Futoshi Kawamata , Shigenori Homma , Hirofumi Kamachi , Takahiro Einama , Yasutaka Kato

DOI: 10.1007/S00535-013-0773-6

关键词: OncologyColorectal cancerMedicineEndotheliumHepatologyLymph node metastasisLymphovascular invasionInternal medicineSurgical oncologyColorectal adenocarcinomaMesothelinGastroenterology

摘要: Background Lymph node metastasis is a key event of colorectal cancer (CRC) progression. Mesothelin expressed in various types malignant tumor and associated with an unfavorable prognosis. The full-length mesothelin (Full-ERC) cleaved by protease into membrane-bound C-ERC/mesothelin N-ERC/mesothelin which secreted the blood. aim this study was to examine biological role CRC clinicopathological analysis vitro lymphatic invasion assay.

参考文章(50)
Nelson G. Ordóñez, Application of mesothelin immunostaining in tumor diagnosis. The American Journal of Surgical Pathology. ,vol. 27, pp. 1418- 1428 ,(2003) , 10.1097/00000478-200311000-00003
TNM classification of malignant tumours Published in <b>2010</b> in Chichester, West Sussex, UK ;Hoboken, NJ by Wiley-Blackwell. ,(1987) , 10.1007/978-3-642-82982-6
Ulrich Nitsche, Matthias Maak, Tibor Schuster, Beat Künzli, Rupert Langer, Julia Slotta-Huspenina, Klaus-Peter Janssen, Helmut Friess, Robert Rosenberg, Prediction of prognosis is not improved by the seventh and latest edition of the TNM classification for colorectal cancer in a single-center collective. Annals of Surgery. ,vol. 254, pp. 793- 801 ,(2011) , 10.1097/SLA.0B013E3182369101
Raffit Hassan, Charles Schweizer, Kun F. Lu, Barbara Schuler, Alan T. Remaley, Susan C. Weil, Ira Pastan, Inhibition of mesothelin–CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy Lung Cancer. ,vol. 68, pp. 455- 459 ,(2010) , 10.1016/J.LUNGCAN.2009.07.016
Kai Chang, Ira Pastan, Mark C. Willingham, Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium. International Journal of Cancer. ,vol. 50, pp. 373- 381 ,(1992) , 10.1002/IJC.2910500308
K. Chang, I. Pastan, Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 136- 140 ,(1996) , 10.1073/PNAS.93.1.136
Toshiaki Watanabe, , Kei Muro, Yoichi Ajioka, Yojiro Hashiguchi, Yoshinori Ito, Yutaka Saito, Tetsuya Hamaguchi, Hideyuki Ishida, Megumi Ishiguro, Soichiro Ishihara, Yukihide Kanemitsu, Hiroshi Kawano, Yusuke Kinugasa, Norihiro Kokudo, Keiko Murofushi, Takako Nakajima, Shiro Oka, Yoshiharu Sakai, Akihito Tsuji, Keisuke Uehara, Hideki Ueno, Kentaro Yamazaki, Masahiro Yoshida, Takayuki Yoshino, Narikazu Boku, Takahiro Fujimori, Michio Itabashi, Nobuo Koinuma, Takayuki Morita, Genichi Nishimura, Yuh Sakata, Yasuhiro Shimada, Keiichi Takahashi, Shinji Tanaka, Osamu Tsuruta, Toshiharu Yamaguchi, Naohiko Yamaguchi, Toshiaki Tanaka, Kenjiro Kotake, Kenichi Sugihara, Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer International Journal of Clinical Oncology. ,vol. 17, pp. 1- 29 ,(2012) , 10.1007/S10147-017-1101-6
Raffit Hassan, Tapan Bera, Ira Pastan, Mesothelin: A new target for immunotherapy Clinical Cancer Research. ,vol. 10, pp. 3937- 3942 ,(2004) , 10.1158/1078-0432.CCR-03-0801
W-F Cheng, C-Y Huang, M-C Chang, Y-H Hu, Y-C Chiang, Y-L Chen, C-Y Hsieh, C-A Chen, High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma. British Journal of Cancer. ,vol. 100, pp. 1144- 1153 ,(2009) , 10.1038/SJ.BJC.6604964